SCHEMBL23809258

SCHEMBL23809258

COCCn1cc(C(=O)O)c2cc(OCCN(C)C)cc(C(C)C)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.41
KDM4E B2RXH2 5/20 0.39
ALDH1A1 P00352 4/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPT P10636 1/20 0.37
CYP1A2 P05177 1/20 0.36
ADRA2A P08913 1/20 0.36
CYP2D6 P10635 1/20 0.36
PKM P14618 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1D P25100 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
ADRA1B P35368 1/20 0.36
DRD3 P35462 1/20 0.36
OPRK1 P41145 1/20 0.36
CHRNA4 P43681 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26581707 0.86 MCL1 (0.46) MCL1KDM4EALDH1A1TDP1MAPT
SCHEMBL26581688 0.76 MAPT (0.45) MCL1ALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL23809280 0.74 CNR1 (0.45) MCL1KDM4EALDH1A1MAPTMEN1
SCHEMBL23809502 0.74 KDM4E (0.49) MCL1KDM4EALDH1A1MAPTADRA1D
SCHEMBL26581708 0.71 MEN1 (0.43) MCL1KDM4EALDH1A1MAPTPKM
SCHEMBL23809470 0.69 KDM4E (0.39) KDM4EALDH1A1TDP1HPGDLMNA
SCHEMBL2035808 0.67 CNR1 (0.44) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL6870269 0.66 MEN1 (0.43) MCL1KDM4EALDH1A1MAPTMEN1
SCHEMBL23809364 0.66 MTNR1A (0.43) MCL1ALDH1A1MAPTMEN1KMT2A
SCHEMBL6869737 0.66 PTGER4 (0.46) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 MCL1 1/4885KDM4E 1156/4885ALDH1A1 2556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.